Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Jul;16(1):9–16. doi: 10.1111/j.1365-2125.1983.tb02137.x

Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.

G R Bellamy, S N Hunyor, D Roffe, J Massang
PMCID: PMC1427951  PMID: 6882628

Abstract

The blood pressure (BP) effect and modes of action of a twice daily regimen of labetalol (mean 450 mg/day) were assessed in ten mild to moderate hypertensives using continuous ambulatory BP monitoring. The reflex control of BP during physiological interventions was examined just prior to the next dose of medication to estimate the residual alpha- and beta-adrenoceptor blockade. Global 24 h BP was reduced by 15/9 mm Hg, and home pressures by 13/11 mm Hg. The predominant antihypertensive effect was noted during the waking hours. During dynamic exercise significant inhibition of the heart rate and blood pressure rise occurred. Coupled with a reduction of the post-release BP 'overshoot' in Valsalva's manoeuvre, the response resembles that seen with beta-adrenoceptor blockade. A small alpha-adrenoceptor blocking action was evident in one patient's response to the Valsalva manoeuvre.

Full text

PDF
9

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balasubramanian V., Mann S., Raftery E. B., Millar-Craig M. W., Altman D. Effect of labetalol on continuous ambulatory blood pressure. Br J Clin Pharmacol. 1979;8(Suppl 2):119S–123S. [PMC free article] [PubMed] [Google Scholar]
  2. Bevan A. T., Honour A. J., Stott F. H. Direct arterial pressure recording in unrestricted man. Clin Sci. 1969 Apr;36(2):329–344. [PubMed] [Google Scholar]
  3. Breit S. N., O'Rourke M. F. Comparison of direct and indirect arterial pressure measurements in hospitalized patients. Aust N Z J Med. 1974 Oct;4(5):485–491. doi: 10.1111/j.1445-5994.1974.tb03222.x. [DOI] [PubMed] [Google Scholar]
  4. Ewing D. J., Irving J. B., Kerr F., Kirby B. J. Static exercise in untreated systemic hypertension. Br Heart J. 1973 Apr;35(4):413–421. doi: 10.1136/hrt.35.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frishman W. H., Strom J. A., Kirschner M., Poland M., Klein N., Halprin S., LeJemtel T. H., Kram M., Sonnenblick E. H. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade. Am J Cardiol. 1981 Nov;48(5):917–928. doi: 10.1016/0002-9149(81)90359-3. [DOI] [PubMed] [Google Scholar]
  6. Gilmore E., Weil J., Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970 Mar 5;282(10):521–527. doi: 10.1056/NEJM197003052821001. [DOI] [PubMed] [Google Scholar]
  7. Hunyor S. N., Bauer G. E., Ross M., Larkin H. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects. Aust N Z J Med. 1980 Apr;10(2):162–166. doi: 10.1111/j.1445-5994.1980.tb03705.x. [DOI] [PubMed] [Google Scholar]
  8. Hunyor S., Nyberg G. Comparison of intra-arterial and indirect blood pressures at rest and during isometric exercise in hypertensive patients before and after metoprolol. Br J Clin Pharmacol. 1978 Aug;6(2):109–114. doi: 10.1111/j.1365-2125.1978.tb00834.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jennings G., Bobik A., Korner P. Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise. Br J Clin Pharmacol. 1981 Sep;12(3):355–362. doi: 10.1111/j.1365-2125.1981.tb01226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lund-Johansen P., Bakke O. M. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension. Br J Clin Pharmacol. 1979 Feb;7(2):169–174. doi: 10.1111/j.1365-2125.1979.tb00917.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Man in 't Veld A. J., Schalekamp M. A. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol. 1982;13(Suppl 2):245S–257S. doi: 10.1111/j.1365-2125.1982.tb01922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maxwell G. M. The effects of a new alpha- and beta-adrenoceptor antagonist (AH5158) upon the general and coronary haemodynamics of intact dogs. Br J Pharmacol. 1973 Oct;49(2):370–372. doi: 10.1111/j.1476-5381.1973.tb08387.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McDevitt D. G., Shand D. G. Plasma concentrations and the time-course of beta blockade due to propranolol. Clin Pharmacol Ther. 1975 Dec;18(6):708–713. doi: 10.1002/cpt1975186708. [DOI] [PubMed] [Google Scholar]
  14. Millar-Craig M. W., Hawes D., Whittington J. New system for recording ambulatory blood pressure in man. Med Biol Eng Comput. 1978 Nov;16(6):727–731. doi: 10.1007/BF02442453. [DOI] [PubMed] [Google Scholar]
  15. Prichard B. N., Boakes A. J., Hernández R. Long-term treatment of hypertension with labetalol. Br J Clin Pharmacol. 1979;8(Suppl 2):171S–177S. [PMC free article] [PubMed] [Google Scholar]
  16. Richards D. A., Prichard B. N., Boakes A. J., Tuckman J., Knight E. J. Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J. 1977 Jan;39(1):99–106. doi: 10.1136/hrt.39.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Skinner C., Gaddie J., Palmer K. N. Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma. Br Med J. 1975 Apr 12;2(5962):59–61. doi: 10.1136/bmj.2.5962.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Williams L. C., Murphy M. J., Parsons V. Labetalol in severe and resistant hypertension. Br J Clin Pharmacol. 1979;8(Suppl 2):143S–147S. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES